Report Detail

Request for Sample of this report

Pharma & Healthcare Global Calcium Channel Antagonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4565010
    • |
  • 07 November, 2023
    • |
  • Global
    • |
  • 133 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Calcium Channel Antagonist market size was valued at USD 1492 million in 2022 and is forecast to a readjusted size of USD 1953.3 million by 2029 with a CAGR of 3.9% during review period.
Calcium channel antagonists, also called calcium channel blockers and calcium antagonists (Calcium Antagonists), abbreviated as CCB in English, are a very important class of drugs for the treatment of hypertension. Calcium channel blockers mainly block calcium ion channels on vascular smooth muscle cells, inhibit the influx of extracellular calcium ions, reduce intracellular calcium ion levels, and cause functional changes in cardiovascular and other tissues and organs, thereby dilating blood vessels and lowering blood pressure. role.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Calcium Channel Antagonist industry chain, the market status of Hospital (Dihydropyridines, Non-dihydropyridines), Clinic (Dihydropyridines, Non-dihydropyridines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Calcium Channel Antagonist.
Regionally, the report analyzes the Calcium Channel Antagonist markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Calcium Channel Antagonist market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Calcium Channel Antagonist market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Calcium Channel Antagonist industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Dihydropyridines, Non-dihydropyridines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Calcium Channel Antagonist market.
Regional Analysis: The report involves examining the Calcium Channel Antagonist market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Calcium Channel Antagonist market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Calcium Channel Antagonist:
Company Analysis: Report covers individual Calcium Channel Antagonist manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Calcium Channel Antagonist This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Calcium Channel Antagonist. It assesses the current state, advancements, and potential future developments in Calcium Channel Antagonist areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Calcium Channel Antagonist market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Calcium Channel Antagonist market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Dihydropyridines
Non-dihydropyridines
Market segment by Application
Hospital
Clinic
Other
Major players covered
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
Kyowa Kirin
Daiichi Sankyo
Shi Huida
Yangtze River
Chengdu Bate
Jiangsu Hengrui
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Calcium Channel Antagonist product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Calcium Channel Antagonist, with price, sales, revenue and global market share of Calcium Channel Antagonist from 2018 to 2023.
Chapter 3, the Calcium Channel Antagonist competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Calcium Channel Antagonist breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Calcium Channel Antagonist market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Calcium Channel Antagonist.
Chapter 14 and 15, to describe Calcium Channel Antagonist sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Calcium Channel Antagonist
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Calcium Channel Antagonist Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Dihydropyridines
    • 1.3.3 Non-dihydropyridines
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Calcium Channel Antagonist Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Calcium Channel Antagonist Market Size & Forecast
    • 1.5.1 Global Calcium Channel Antagonist Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Calcium Channel Antagonist Sales Quantity (2018-2029)
    • 1.5.3 Global Calcium Channel Antagonist Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Calcium Channel Antagonist Product and Services
    • 2.1.4 Pfizer Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Aventis
    • 2.2.1 Aventis Details
    • 2.2.2 Aventis Major Business
    • 2.2.3 Aventis Calcium Channel Antagonist Product and Services
    • 2.2.4 Aventis Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Aventis Recent Developments/Updates
  • 2.3 Searle
    • 2.3.1 Searle Details
    • 2.3.2 Searle Major Business
    • 2.3.3 Searle Calcium Channel Antagonist Product and Services
    • 2.3.4 Searle Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Searle Recent Developments/Updates
  • 2.4 Bayer
    • 2.4.1 Bayer Details
    • 2.4.2 Bayer Major Business
    • 2.4.3 Bayer Calcium Channel Antagonist Product and Services
    • 2.4.4 Bayer Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Bayer Recent Developments/Updates
  • 2.5 AstraZeneca
    • 2.5.1 AstraZeneca Details
    • 2.5.2 AstraZeneca Major Business
    • 2.5.3 AstraZeneca Calcium Channel Antagonist Product and Services
    • 2.5.4 AstraZeneca Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 AstraZeneca Recent Developments/Updates
  • 2.6 Knoll Pharmaceuticals
    • 2.6.1 Knoll Pharmaceuticals Details
    • 2.6.2 Knoll Pharmaceuticals Major Business
    • 2.6.3 Knoll Pharmaceuticals Calcium Channel Antagonist Product and Services
    • 2.6.4 Knoll Pharmaceuticals Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Knoll Pharmaceuticals Recent Developments/Updates
  • 2.7 Wyeth-Ayerst
    • 2.7.1 Wyeth-Ayerst Details
    • 2.7.2 Wyeth-Ayerst Major Business
    • 2.7.3 Wyeth-Ayerst Calcium Channel Antagonist Product and Services
    • 2.7.4 Wyeth-Ayerst Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Wyeth-Ayerst Recent Developments/Updates
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Calcium Channel Antagonist Product and Services
    • 2.8.4 AstraZeneca Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 AstraZeneca Recent Developments/Updates
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis Calcium Channel Antagonist Product and Services
    • 2.9.4 Novartis Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Novartis Recent Developments/Updates
  • 2.10 Sanofi
    • 2.10.1 Sanofi Details
    • 2.10.2 Sanofi Major Business
    • 2.10.3 Sanofi Calcium Channel Antagonist Product and Services
    • 2.10.4 Sanofi Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Sanofi Recent Developments/Updates
  • 2.11 Kyowa Kirin
    • 2.11.1 Kyowa Kirin Details
    • 2.11.2 Kyowa Kirin Major Business
    • 2.11.3 Kyowa Kirin Calcium Channel Antagonist Product and Services
    • 2.11.4 Kyowa Kirin Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Kyowa Kirin Recent Developments/Updates
  • 2.12 Daiichi Sankyo
    • 2.12.1 Daiichi Sankyo Details
    • 2.12.2 Daiichi Sankyo Major Business
    • 2.12.3 Daiichi Sankyo Calcium Channel Antagonist Product and Services
    • 2.12.4 Daiichi Sankyo Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Daiichi Sankyo Recent Developments/Updates
  • 2.13 Shi Huida
    • 2.13.1 Shi Huida Details
    • 2.13.2 Shi Huida Major Business
    • 2.13.3 Shi Huida Calcium Channel Antagonist Product and Services
    • 2.13.4 Shi Huida Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Shi Huida Recent Developments/Updates
  • 2.14 Yangtze River
    • 2.14.1 Yangtze River Details
    • 2.14.2 Yangtze River Major Business
    • 2.14.3 Yangtze River Calcium Channel Antagonist Product and Services
    • 2.14.4 Yangtze River Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Yangtze River Recent Developments/Updates
  • 2.15 Chengdu Bate
    • 2.15.1 Chengdu Bate Details
    • 2.15.2 Chengdu Bate Major Business
    • 2.15.3 Chengdu Bate Calcium Channel Antagonist Product and Services
    • 2.15.4 Chengdu Bate Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Chengdu Bate Recent Developments/Updates
  • 2.16 Jiangsu Hengrui
    • 2.16.1 Jiangsu Hengrui Details
    • 2.16.2 Jiangsu Hengrui Major Business
    • 2.16.3 Jiangsu Hengrui Calcium Channel Antagonist Product and Services
    • 2.16.4 Jiangsu Hengrui Calcium Channel Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Jiangsu Hengrui Recent Developments/Updates

3 Competitive Environment: Calcium Channel Antagonist by Manufacturer

  • 3.1 Global Calcium Channel Antagonist Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Calcium Channel Antagonist Revenue by Manufacturer (2018-2023)
  • 3.3 Global Calcium Channel Antagonist Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Calcium Channel Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Calcium Channel Antagonist Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Calcium Channel Antagonist Manufacturer Market Share in 2022
  • 3.5 Calcium Channel Antagonist Market: Overall Company Footprint Analysis
    • 3.5.1 Calcium Channel Antagonist Market: Region Footprint
    • 3.5.2 Calcium Channel Antagonist Market: Company Product Type Footprint
    • 3.5.3 Calcium Channel Antagonist Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Calcium Channel Antagonist Market Size by Region
    • 4.1.1 Global Calcium Channel Antagonist Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Calcium Channel Antagonist Consumption Value by Region (2018-2029)
    • 4.1.3 Global Calcium Channel Antagonist Average Price by Region (2018-2029)
  • 4.2 North America Calcium Channel Antagonist Consumption Value (2018-2029)
  • 4.3 Europe Calcium Channel Antagonist Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Calcium Channel Antagonist Consumption Value (2018-2029)
  • 4.5 South America Calcium Channel Antagonist Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Calcium Channel Antagonist Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Calcium Channel Antagonist Sales Quantity by Type (2018-2029)
  • 5.2 Global Calcium Channel Antagonist Consumption Value by Type (2018-2029)
  • 5.3 Global Calcium Channel Antagonist Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Calcium Channel Antagonist Sales Quantity by Application (2018-2029)
  • 6.2 Global Calcium Channel Antagonist Consumption Value by Application (2018-2029)
  • 6.3 Global Calcium Channel Antagonist Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Calcium Channel Antagonist Sales Quantity by Type (2018-2029)
  • 7.2 North America Calcium Channel Antagonist Sales Quantity by Application (2018-2029)
  • 7.3 North America Calcium Channel Antagonist Market Size by Country
    • 7.3.1 North America Calcium Channel Antagonist Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Calcium Channel Antagonist Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Calcium Channel Antagonist Sales Quantity by Type (2018-2029)
  • 8.2 Europe Calcium Channel Antagonist Sales Quantity by Application (2018-2029)
  • 8.3 Europe Calcium Channel Antagonist Market Size by Country
    • 8.3.1 Europe Calcium Channel Antagonist Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Calcium Channel Antagonist Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Calcium Channel Antagonist Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Calcium Channel Antagonist Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Calcium Channel Antagonist Market Size by Region
    • 9.3.1 Asia-Pacific Calcium Channel Antagonist Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Calcium Channel Antagonist Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Calcium Channel Antagonist Sales Quantity by Type (2018-2029)
  • 10.2 South America Calcium Channel Antagonist Sales Quantity by Application (2018-2029)
  • 10.3 South America Calcium Channel Antagonist Market Size by Country
    • 10.3.1 South America Calcium Channel Antagonist Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Calcium Channel Antagonist Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Calcium Channel Antagonist Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Calcium Channel Antagonist Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Calcium Channel Antagonist Market Size by Country
    • 11.3.1 Middle East & Africa Calcium Channel Antagonist Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Calcium Channel Antagonist Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Calcium Channel Antagonist Market Drivers
  • 12.2 Calcium Channel Antagonist Market Restraints
  • 12.3 Calcium Channel Antagonist Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Calcium Channel Antagonist and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Calcium Channel Antagonist
  • 13.3 Calcium Channel Antagonist Production Process
  • 13.4 Calcium Channel Antagonist Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Calcium Channel Antagonist Typical Distributors
  • 14.3 Calcium Channel Antagonist Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Calcium Channel Antagonist. Industry analysis & Market Report on Calcium Channel Antagonist is a syndicated market report, published as Global Calcium Channel Antagonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Calcium Channel Antagonist market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,745.72
    		4,118.58
    		5,491.44
    		3,201.60
    		4,802.40
    		6,403.20
    		539,991.60
    		809,987.40
    		1,079,983.20
    		290,580.00
    		435,870.00
    		581,160.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo